FDA Approves Nausea Prevention Drug
- By admin aapc
- In Industry News
- September 2, 2008
- Comments Off on FDA Approves Nausea Prevention Drug
The FDA has approved a new oral formulation of ALOXI(R) (palonosetron hydrochloride) made by Eisai Corporation of North America and its partner Helsinn Healthcare SA for the prevention of chemotherapy-induced nausea and vomiting (CINV) (Medical News Today, Aug. 24).
Latest posts by admin aapc (see all)
- AAPC Facebook Social Hour - February 25, 2021
- Beloved AAPC Member Is Remembered - February 17, 2021
- I Am AAPC: Julio Paque Pena, MHA, CPC, CPCO, CDEO, CPB, CPMA, CRC - February 1, 2021
